FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1984-1985 December 26, 1996 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Physicians have long struggled with the vexing problem of how best to treat patients with myocardial infarction, reduced left ventricular function, and asymptomatic unsustained ventricular tachycardia who may be at risk for sudden death due to ventricular fibrillation. The Multicenter Automatic Defibrillator Implantation Trial (MADIT) was a randomized clinical trial that addressed whether such patients might benefit from an implantable cardioverter–defibrillator. In this trial patients with asymptomatic unsustained ventricular tachycardia who had inducible sustained ventricular tachycardia or ventricular fibrillation that remained inducible after the intravenous administration of procainamide were randomly assigned to receive implantable cardioverter–defibrillators or antiarrhythmic-drug therapy. The results . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Eisenberg, M. J. (2001). Risk stratification for arrhythmic events: are the bangs worth the bucks?. J Am Coll Cardiol 38: 1912-1915 [Full Text]  
• Boriani, G, Biffi, M, Martignani, C, Gallina, M, Branzi, A (2001). Cost-effectiveness of implantable cardioverter-defibrillators. Eur Heart J 22: 990-996  
• Myerburg, R. J, Spooner, P. M (2001). Opportunities for sudden death prevention: Directions for new clinical and basic research. Cardiovasc Res 50: 177-185 [Abstract] [Full Text]  
• Cice, G., Tagliamonte, E., Ferrara, L., Iacono, A. (2000). Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study. Eur Heart J 21: 1259-1264 [Abstract]  
• Zimetbaum, P. J., Josephson, M. E. (1999). The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice. ANN INTERN MED 130: 848-856 [Abstract] [Full Text]  
• Mushlin, A. I., Hall, W. J., Zwanziger, J., Gajary, E., Andrews, M., Marron, R., Zou, K. H., Moss, A. J. (1998). The Cost-effectiveness of Automatic Implantable Cardiac Defibrillators: : Results From MADIT. Circulation 97: 2129-2135 [Abstract] [Full Text]  
• Cecchi, F, Olivotto, I, Montereggi, A, Squillatini, G, Dolara, A, Maron, B J (1998). Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart 79: 331-336 [Abstract] [Full Text]  
• Myerburg, R. J., Castellanos, A. (1997). Clinical Trials of Implantable Defibrillators. NEJM 337: 1621-1623 [Full Text]  
• Domanski, M. J., Zipes, D. P., Schron, E. (1997). Treatment of Sudden Cardiac Death : Current Understandings From Randomized Trials and Future Research Directions. Circulation 95: 2694-2699 [Full Text]  
• (1997). THE IMPLANTED DEFIBRILLATOR FOR UNSUSTAINED VT. JWatch General 1997: 4-4 [Full Text]  
• Saksena, S., Giorgberidze, I. (1997). The Multicenter Automatic Defibrillator Implantation Trial: MADIT Provides the Basis for Developing Therapeutic Strategy for Patients With Severely Depressed Ventricular Ejection Fraction With Nonsustained Ventricular Tachycardia. J CARDIOVASC PHARMACOL THER 2: 229-234  
• Epstein, A. E. (1997). MADIT Does Not Provide the Basis for Developing Therapeutic Strategy for Patients With Severely Depressed Ventricular Ejection Fraction With Nonsustained Ventricular Tachycardia. J CARDIOVASC PHARMACOL THER 2: 234-237